Resumption of India's COVAX vaccine supply delayed by Nepal - sources

The resumption of India supplying COVID-19 vaccines to the global COVAX vaccine-sharing platform after eight months was delayed on Monday when Nepal requested a postponement, two sources told Reuters. The Serum Institute of India (SII), the world's biggest vaccine maker, was scheduled to ship Covishield doses through COVAX to Nepal on Monday, but the country now wants them only around Nov. 29, said one of the sources, a Nepal health ministry official. He declined to explain the reasons for the delay. Neither source wanted to be named ahead of vaccine delivery, expected to be in hundreds of thousands of doses.